Gladstone NOW: The Campaign Join Us on the Journey ✕
46 - 60 of 125 Results Clear All
Gladstone scientists discover how the novel coronavirus damages heart muscle cells, and create a system that can be used to screen potential therapies
News Release Research (Publication) COVID-19 Cardiovascular Disease Virology Conklin Lab McDevitt Lab Ott Lab
The Mercury News—Director of Gladstone Institute of Virology Melanie Ott, MD, PhD, comments on the new coronavirus variants and says vaccines currently distributed in the US protect against hospitalization and death from COVID-19.
Gladstone Experts COVID-19 Virology Ott Lab
San Francisco Business Times—Melanie Ott, MD, PhD, director of the Gladstone Institute of Virology, is one of several key Bay Area women life scientists sharing their views on their careers, the pandemic, and the path ahead for women leaders.
Gladstone Experts COVID-19 Virology Ott Lab
A Gladstone discovery could be selected as the top innovation in biomedicine
Awards COVID-19 Doudna Lab Krogan Lab Ott Lab CRISPR/Gene Editing
San Francisco Chronicle—New coronavirus variants are emerging around the world, including in the Bay Area. Melanie Ott, director of the Gladstone Institute of Virology, explains that if the vaccine rollout isn’t fast enough, viral variants that can evade the vaccine may become prevalent, rendering the vaccine partially ineffective.
Gladstone Experts COVID-19 Virology Ott Lab
ABC7 News—Gladstone Institute of Virology Director Melanie Ott, MD, PhD, and Graduate Student Parinaz Fozouni comment on the COVID-19 detection test they recently developed with Nobel Laureate Jennifer Doudna, PhD, and UC Berkeley Professor Dan Fletcher, PhD, using CRISPR and smartphone technology.
Gladstone Experts COVID-19 Virology Doudna Lab Ott Lab CRISPR/Gene Editing
Melanie Ott helped shape recommendations for a unified plan to end the pandemic
Gladstone Experts COVID-19 Ott Lab
Forbes—In an article about the need for rapid testing to monitor and curb the COVID-19 pandemic, Melanie Ott, MD, PhD, director of the Gladstone Institute of Virology, explains the advantages of the CRISPR- and smartphone-based detection platform she developed with Senior Investigator and Nobel Laureate Jennifer Doudna, PhD, and UC Berkeley Professor Dan Fletcher, PhD.
Gladstone Experts COVID-19 Data Science and Biotechnology Virology Doudna Lab Ott Lab
San Francisco Business Times—Melanie Ott, MD, PhD, director of the Gladstone Institute of Virology, discusses the rapid, smartphone-based Coronavirus detection assay her group recently described in the scientific publication Cell. The assay was developed by Graduate Student Parinaz Fozouni, in collaboration with the labs of Senior Scientist and Nobel Laureate Jennifer Doudna, PhD, and of UC Berkeley Bioengineering Professor Dan Fletcher, PhD.
Gladstone Experts COVID-19 Data Science and Biotechnology Virology Doudna Lab Ott Lab
The new study points toward ways to treat not only COVID-19, but future coronaviruses that might emerge
News Release Research (Publication) COVID-19 Virology Krogan Lab Ott Lab
The rapid, one-step mobile test could help combat the pandemic and fully reopen communities
News Release COVID-19 Data Science and Biotechnology Virology Doudna Lab Ott Lab CRISPR/Gene Editing
Nature—Melanie Ott, MD, PhD, director of the Gladstone Institute of Virology, explains how the CRISPR-based coronavirus test she recently developed with Nobel Laureate and Senior Investigator Jennifer Doudna, PhD, measures up against conventional, PCR-based tests.
Gladstone Experts COVID-19 Virology Doudna Lab Ott Lab CRISPR/Gene Editing
USA Today—Senior Investigator and Nobel Laureate Jennifer Doudna, PhD, shares her view of CRISPR-based coronavirus detection kits and the possibility they might be deployed during the current pandemic. She and Senior Investigator Melanie Ott, MD, PhD, recently described the test they developed together in a publication posted on the electronic preprint platform bioRxiv.
Gladstone Experts COVID-19 Data Science and Biotechnology Virology Doudna Lab Ott Lab CRISPR/Gene Editing
Science is Fun!—Director of the Gladstone Institute of Virology Melanie Ott describes her latest work developing a CRISPR-based test for COVID-19, and the prospect for broadly acting antiviral therapeutics.
Gladstone Experts COVID-19 Virology Ott Lab
Life Science—The online science news hub Life Sciences highlights recent work from Senior Investigators Melanie Ott, MD, PhD, and Nevan Krogan, PhD, and their colleagues at BioHub and Synthego Corporation. The work describes the identification of host factors common to three coronaviruses including SARS-CoV-2, and could help bootstrap efforts to stem current and future coronavirus epidemics.
Gladstone Experts COVID-19 Data Science and Biotechnology Virology Krogan Lab Ott Lab CRISPR/Gene Editing
